Chicago Cardio Diagnostics LLC is categorized under Primary Care Centers in Schaumburg, IL and active since 2005.
Chicago Cardio Diagnostics LLC was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Primary Care Centers business, which does work in the B2C market, and is classified as a Primary Care Centers, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Matthew L Desrosiers at the company’s single location by writing to 270 Willoby Court, Schaumburg, Illinois IL 60173 or by phoning (847) 251-6800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chicago Cardio Diagnostics LLC |
| Contact Person: | Matthew L Desrosiers |
| Address: | 270 Willoby Court, Schaumburg, Illinois 60173 |
| Phone Number: | (847) 251-6800 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Primary Care Centers |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Chicago Cardio Diagnostics LLC was started in 2005 to provide professional Primary Care Centers under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Matthew L Desrosiers for inquiries that concern Chicago Cardio Diagnostics LLC by calling the company number (847) 251-6800, as your correspondence is most welcome. Additionally, the physical location of the single location of Chicago Cardio Diagnostics LLC can be found at the coordinates as well as the street address 270 Willoby Court in Schaumburg, Illinois 60173.
For its online presence, you may visit Chicago Cardio Diagnostics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.